John Varga

9.6k total citations
49 papers, 2.0k citations indexed

About

John Varga is a scholar working on Pathology and Forensic Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, John Varga has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 15 papers in Rheumatology and 13 papers in Molecular Biology. Recurrent topics in John Varga's work include Systemic Sclerosis and Related Diseases (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Eosinophilic Disorders and Syndromes (7 papers). John Varga is often cited by papers focused on Systemic Sclerosis and Related Diseases (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Eosinophilic Disorders and Syndromes (7 papers). John Varga collaborates with scholars based in United States, Hungary and United Kingdom. John Varga's co-authors include Sergio A. Jiménez, Shu-Jen Chen, Benjamin D. Korman, Roberta Gonçalves Marangoni, Yasuji Mori, Weihua Yuan, Jouni Uitto, Warren G. Tourtellotte, Asish K. Ghosh and Veli‐Matti Kähäri and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

John Varga

48 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Varga United States 26 683 636 373 371 334 49 2.0k
Kenichi Yamane Japan 28 1.0k 1.5× 942 1.5× 233 0.6× 460 1.2× 311 0.9× 69 2.4k
Yoshinao Soma Japan 24 426 0.6× 420 0.7× 330 0.9× 499 1.3× 223 0.7× 79 1.8k
Tamihiro Kawakami Japan 26 765 1.1× 484 0.8× 735 2.0× 503 1.4× 359 1.1× 126 2.4k
Raphaël Lemaire United States 22 716 1.0× 701 1.1× 269 0.7× 229 0.6× 393 1.2× 31 1.7k
Yasuji Mori United States 24 606 0.9× 1.4k 2.2× 244 0.7× 415 1.1× 233 0.7× 27 2.4k
Jun Wei United States 23 994 1.5× 826 1.3× 154 0.4× 453 1.2× 356 1.1× 31 2.1k
Zenshiro Tamaki Japan 21 928 1.4× 451 0.7× 217 0.6× 347 0.9× 495 1.5× 53 1.7k
Alfiya Distler Germany 29 1.0k 1.5× 1.3k 2.0× 413 1.1× 313 0.8× 549 1.6× 55 2.9k
Silvia Svegliati Italy 25 1.0k 1.5× 606 1.0× 307 0.8× 383 1.0× 623 1.9× 43 2.1k
Steven O’Reilly United Kingdom 33 1.2k 1.7× 898 1.4× 259 0.7× 436 1.2× 829 2.5× 77 2.7k

Countries citing papers authored by John Varga

Since Specialization
Citations

This map shows the geographic impact of John Varga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Varga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Varga more than expected).

Fields of papers citing papers by John Varga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Varga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Varga. The network helps show where John Varga may publish in the future.

Co-authorship network of co-authors of John Varga

This figure shows the co-authorship network connecting the top 25 collaborators of John Varga. A scholar is included among the top collaborators of John Varga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Varga. John Varga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernstein, Elana J., Francesco Boin, Brett M. Elicker, et al.. (2024). FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease. Lara D. Veeken. 64(SI). SI73–SI78. 3 indexed citations
2.
Marangoni, Roberta Gonçalves, Benjamin D. Korman, Edwin R. Parra, et al.. (2021). Pathological pulmonary vascular remodeling is induced by type V collagen in a model of scleroderma. Pathology - Research and Practice. 220. 153382–153382. 4 indexed citations
3.
Korman, Benjamin D., et al.. (2018). Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis. Arthritis Research & Therapy. 20(1). 145–145. 29 indexed citations
4.
Marangoni, Roberta Gonçalves, Yuri Masui, Feng Fang, et al.. (2017). Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target. Scientific Reports. 7(1). 4397–4397. 68 indexed citations
5.
Wei, Jun, Hongyan Zhu, Graham P. Allaway, et al.. (2016). Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative. Translational research. 183. 71–86.e1. 29 indexed citations
6.
Richardson, Carrie, Rishi Agrawal, Jungwha Lee, et al.. (2016). Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study. Seminars in Arthritis and Rheumatism. 46(1). 109–114. 49 indexed citations
7.
Marangoni, Roberta Gonçalves, Benjamin D. Korman, Yannick Allanore, et al.. (2015). A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis. Arthritis Research & Therapy. 17(1). 128–128. 24 indexed citations
8.
Hinchcliff, Monique, Jennifer L. Beaumont, Mary Carns, et al.. (2014). Longitudinal Evaluation of PROMIS-29 and FACIT-Dyspnea Short Forms in Systemic Sclerosis. The Journal of Rheumatology. 42(1). 64–72. 44 indexed citations
9.
Wei, Jun, Swati Bhattacharyya, Manu Jain, & John Varga. (2012). Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis. The Open Rheumatology Journal. 6(1). 103–115. 44 indexed citations
10.
Rose, Shawn & John Varga. (2010). Diffuse Palpable Tendon Friction Rubs in a Patient with Seronegative Erosive Polyarthritis. JCR Journal of Clinical Rheumatology. 16(6). 300–301. 1 indexed citations
11.
Khalidi, Nader, et al.. (2005). Coexisting Systemic Lupus Erythematosus and Sickle Cell Disease. JCR Journal of Clinical Rheumatology. 11(2). 86–92. 23 indexed citations
12.
Ghosh, Asish K., Weihua Yuan, Yasuji Mori, Shu-Jen Chen, & John Varga. (2001). Antagonistic Regulation of Type I Collagen Gene Expression by Interferon-γ and Transforming Growth Factor-β. Journal of Biological Chemistry. 276(14). 11041–11048. 195 indexed citations
13.
Varga, John. (2000). Progress in systemic sclerosis: Novel therapeutic paradigms. Current Rheumatology Reports. 2(6). 481–485. 1 indexed citations
14.
Yuan, Weihua, Tatyana Yufit, Liye Li, et al.. (1999). Negative modulation of ?1(I) procollagen gene expression in human skin fibroblasts: Transcriptional inhibition by interferon-?. Journal of Cellular Physiology. 179(1). 97–108. 56 indexed citations
15.
Chen, Shu-Jen, Carol M. Artlett, Sergio A. Jiménez, & John Varga. (1998). Modulation of human α1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. Gene. 215(1). 101–110. 66 indexed citations
16.
17.
Jiménez, Sergio A., et al.. (1997). Increased activity of the α1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome. The International Journal of Biochemistry & Cell Biology. 29(1). 135–141. 7 indexed citations
18.
Jiménez, Sergio A., et al.. (1996). PATHOGENESIS OF SCLERODERMA. Rheumatic Disease Clinics of North America. 22(4). 647–674. 150 indexed citations
19.
Varga, John, Tatyana Yufit, & R. R. Brown. (1995). Inhibition of collagenase and stromelysin gene expression by interferon-gamma in human dermal fibroblasts is mediated in part via induction of tryptophan degradation.. Journal of Clinical Investigation. 96(1). 475–481. 35 indexed citations
20.
Varga, John, Terry Heiman‐Patterson, Santiago J. Muñoz, & Lori A. Love. (1993). Myopathy with mitochondrial alterations in patients with primary biliary cirrhosis and antimitochondrial antibodies. Arthritis & Rheumatism. 36(10). 1468–1475. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichi Yamane Breakdown of academic impact, for papers by Yoshinao Soma Breakdown of academic impact, for papers by Tamihiro Kawakami Breakdown of academic impact, for papers by Raphaël Lemaire Breakdown of academic impact, for papers by Yasuji Mori Breakdown of academic impact, for papers by Jun Wei Breakdown of academic impact, for papers by Zenshiro Tamaki Breakdown of academic impact, for papers by Alfiya Distler Breakdown of academic impact, for papers by Silvia Svegliati Breakdown of academic impact, for papers by Steven O’Reilly
Rankless by CCL
2026